GlassScriptPhysician profile
Peter W Gregor
NPI 1528021235
$771.80
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $55.53 · 2021: $292 · 2022: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $219.69 | 2019-2022 | |
| Boston Scientific Corporation | $151.88 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $95.23 | 2019 | |
| Impulse Dynamics (USA) INC. | $87.80 | 2021 | |
| Abbott Laboratories | $81.70 | 2021 | |
| Amgen INC. | $62.46 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $46.62 | 2019-2021 | |
| Pfizer INC. | $13.31 | 2021 | |
| Merck Sharp & Dohme LLC | $13.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Gregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.